🇺🇸 FDA
Patent

US 7704527

Modified release compositions of milnacipran

granted A61KA61K31/165A61K9/2054

Quick answer

US patent 7704527 (Modified release compositions of milnacipran) held by Collegium Pharmaceutical, Inc. expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Collegium Pharmaceutical, Inc.
Grant date
Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/165, A61K9/2054, A61K9/2846, A61P